Bio Techne Corp Stock Fundamentals
| TE1 Stock | 73.50 0.50 0.68% |
Bio Techne Corp fundamentals help investors to digest information that contributes to Bio-Techne Corp's financial success or failures. It also enables traders to predict the movement of Bio-Techne Stock. The fundamental analysis module provides a way to measure Bio-Techne Corp's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bio-Techne Corp stock.
Bio-Techne |
Bio Techne Corp Company Current Valuation Analysis
Bio-Techne Corp's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Bio-Techne Corp Current Valuation | 13.06 B |
Most of Bio-Techne Corp's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bio Techne Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Bio Techne Corp has a Current Valuation of 13.06 B. This is much higher than that of the sector and significantly higher than that of the Current Valuation industry. The current valuation for all Germany stocks is notably lower than that of the firm.
Bio Techne Corp Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Bio-Techne Corp's current stock value. Our valuation model uses many indicators to compare Bio-Techne Corp value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bio-Techne Corp competition to find correlations between indicators driving Bio-Techne Corp's intrinsic value. More Info.Bio Techne Corp is rated below average in current valuation category among its peers. It also is rated below average in price to book category among its peers . The ratio of Current Valuation to Price To Book for Bio Techne Corp is about 1,727,870,166 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bio-Techne Corp's earnings, one of the primary drivers of an investment's value.Bio-Techne Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bio-Techne Corp's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bio-Techne Corp could also be used in its relative valuation, which is a method of valuing Bio-Techne Corp by comparing valuation metrics of similar companies.Bio Techne is currently under evaluation in current valuation category among its peers.
Bio-Techne Fundamentals
| Current Valuation | 13.06 B | |||
| Price To Book | 7.56 X | |||
| Price To Sales | 12.34 X | |||
| Revenue | 1.11 B | |||
| EBITDA | 413.76 M | |||
| Net Income | 272.05 M | |||
| Total Debt | 243.41 M | |||
| Cash Flow From Operations | 325.27 M | |||
| Price To Earnings To Growth | 1.11 X | |||
| Market Capitalization | 16.22 B | |||
| Total Asset | 2.29 B | |||
| Z Score | 39.6 | |||
| Annual Yield | 0.01 % | |||
| Net Asset | 2.29 B |
About Bio-Techne Corp Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bio Techne Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bio-Techne Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bio Techne Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Bio-Techne Stock Analysis
When running Bio-Techne Corp's price analysis, check to measure Bio-Techne Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio-Techne Corp is operating at the current time. Most of Bio-Techne Corp's value examination focuses on studying past and present price action to predict the probability of Bio-Techne Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio-Techne Corp's price. Additionally, you may evaluate how the addition of Bio-Techne Corp to your portfolios can decrease your overall portfolio volatility.